Clinicopathological Significance of Lymphangiogenesis and Tumor Lymphovascular Invasion in Indonesian Breast Cancers |
Widodo, Irianiwati
(Department of Anatomical Pathology, Faculty of Medicine, Gadjah Mada University)
Ferronika, Paranita (Department of Anatomical Pathology, Faculty of Medicine, Gadjah Mada University) Harijadi, Ahmad (Department of Anatomical Pathology, Faculty of Medicine, Gadjah Mada University) Triningsih, F.X. Ediati (Department of Anatomical Pathology, Faculty of Medicine, Gadjah Mada University) Utoro, Totok (Department of Anatomical Pathology, Faculty of Medicine, Gadjah Mada University) Soeripto, Soeripto (Department of Anatomical Pathology, Faculty of Medicine, Gadjah Mada University) |
1 | Beasley NJ, Prevo R, Banerji S, et al (2002). Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res, 62, 1315-20. |
2 | Botting SK, Fouad H, Elwell K, Rampy BA, Salama SA, Freeman DH, Diaz-nastia CR. 2010. Prognostic significance of peritumoral lymphatic vessel density and vascular endothelial growth factor receptor3 in invasive squamous cell cervical cancer. Transl Oncol, 3, 170-5. DOI |
3 | Donegan WL (1997). Tumor related prognostic factor for breast cancer. Cancer J Clin, 47, 28. DOI ScienceOn |
4 | El Ghohary YM, Metwally G, Saad RS, et al (2008). Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas. Am J Clin Pathol, 129, 578-86. DOI ScienceOn |
5 | Furudoi A, Tanaka S, Haruma K, et al (2002). Clinical significance of VEGF-C and angiogenesis at the deepest invasive of advance colorectal carcinoma. Oncology, 62, 157-66. DOI ScienceOn |
6 | Kinoshita J, Kitamura K, Kabashima A, et al (2001). Clinical significancer of vascular endothelial growth factors-C in breast cancer. Breast Cancer Res Treat, 66, 159-64. DOI ScienceOn |
7 | Marinho VFZ, Metze K, Sanches FS, Rocha GFS, Gobbi H (2008). Lymph vascular invasion in invasive mammary carcinomas indentified by the endothelial lymphatic marker D2-40 is associated with other indicatiors of poor prognosis. BMC Cancer, 8, 64. DOI ScienceOn |
8 | Nakamura Y, Yasuoka H, Tsujimoto M, et al (2003). Clinicopathological significance of VEGF-C in breast carcinoma with long-term follow-up. Mod Pathol, 16, 309-14. DOI ScienceOn |
9 | Ogawa E, Takenaka K, Yanagihara K, et al (2004). Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. Br J Cancer, 91, 498-503. DOI ScienceOn |
10 | Papper MS (2001). Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res, 7, 462-8. |
11 | Schoppmann SF, Bayer G, Aumayr K, et al (2004). Prognostic value of lymphangiogenesis and lymphovascular invasion in invasion in invasive breast cancer. Ann Surg, 240, 306-12. DOI ScienceOn |
12 | Schoppmann SF, Fenzl A, Nagy K, et al (2006). VEGF-C expressing TAMs in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery, 139, 839-46. DOI ScienceOn |
13 | Sundar SS, Ganesa TS (2007). Role of lymphangiogenesis in Cancer. J Clin Oncol, 25, 4298-307. DOI ScienceOn |
14 | Tavassoli FA, dan Devilee P (2003). WHO Classification of tumours. Pathology and genetics. Tumours of the breast and female genital organs, IARC Press, Lyon. |
15 | Teguh A, Harijadi, Ahmad G (2000) Correlation of clinical, pathological status, hormone receptor and C-erb-2 oncoprotein in breast cancer patients. Jpn J Cancer Chemother, 27, 600-6. |
16 | Tezuka K, Onoda N, Takashima T, et al (2007). Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients. Oncol Rep, 17, 997-1003. |
17 | Teramoto S, Arihiro K, Koseki M, et al (2008), Role of VEGF-C and D mRNA in breast cancer. Hiroshima J Med Sci, 57, 73-8 |
18 | Yonemura Y, Endo Y, Fijuta H, et al (1999). Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Mol Oncol, 5, 1823-9. |
19 | Yavuz S, Paydas S, Disel U, Zorludemir S, Erdogan S (2005). VEGF-C expression in breast cancer: clinical importance. Adv Ther, 22, 368-77. DOI |
20 | Yokoyama Y, Charnock-Jones DS, Licence D, et al (2003). VEGF-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer, 88, 237-44. DOI ScienceOn |
21 | Zhang XH, Huang DP, Guo GL, et al (2008) Coexpression of VEGF and COX-2 and its association with lymphangiogenesis in human breast cancer. BMC Cancer, 8, 1-8. DOI ScienceOn |